Sign in

Albert DaCosta

Chairman, President, and Chief Executive Officer at FNA
Board
Since 2012
Age
50 years
Education
Earned a B.S. in Chemical Engineering with a minor in Business from the University of Florida.
Tenure
Joined FNA in 2012 as a co-founder and has served as Chairman, President, and Chief Executive Officer, in addition to being a Board member since that year.

Also at FNA

KW
Kristina Wright
Interim Chief Financial Officer
CC
Chadi Chahine
Chief Financial Officer and Executive Vice President of Supply Chain Operations
DH
Drew Hill
Executive Vice President of Research and Development

About

Albert DaCosta is the co-founder and key executive driving FNA, having played a critical role in its formation and sustained growth since 2012. With over 18 years of experience in the foot and ankle industry, he laid the foundation for FNA’s evolution by leveraging his deep industry expertise and strategic vision.

Educated in Chemical Engineering with a minor in Business from the University of Florida, he has applied his technical knowledge and leadership skills to innovate within the medical device field. His early career included significant roles ranging from a sales representative to a distributor and even founding his own ventures, which helped shape his capabilities as a business leader.

Throughout his professional journey, his contributions have been instrumental in establishing a strong corporate culture and driving innovation, ensuring that FNA remains competitive in the highly specialized healthcare sector. His leadership not only underscores his dedication to excellence in this niche industry but also reflects his broader commitment to advancing healthcare solutions.

$FNA Performance Under Albert DaCosta

Past Roles

Organization Role Date Range Details
Pioneer Surgical and Biomet Sports Medicine Distributor 2009-2010 Worked as distributor for these companies
Wright Medical Director of Biologics & Extremities N/A [N/A]Served in a director role
Body Beautiful Laser Centers President & Founder 2006 Based in South Florida
Non-Invasive Solutions President 2005 N/A [N/A]
Linvatec Sales Representative 2003 N/A [N/A]

Fixed Compensation

Data from  FY 2023
Component NameAmount (USD)Payment ScheduleAdditional Details
Salary$700,769 AnnualFixed base salary
401(k) Plan Contribution$9,990 Annual401(k) contribution
Executive Level Insurance Benefits (Medical, Life, and Disability)$21,857 AnnualGroup insurance benefits

Performance Compensation

Data from  FY 2023

Non-Equity Incentive Plan

Metric DescriptionValueDetails/Conditions
Target Annual Cash Bonus Opportunity100% of base salaryImplies bonus target equals annualized base salary
Threshold Payout$355,000 Achieved at 50% of target if revenue objective met at threshold
Target Payout$710,000 Base target payout
Maximum Payout$1,420,000 Capped at 200% of target with maximum revenue and adjusted free cash flow achievement
Actual Bonus Award$667,400 Represents 94% of the target payout based on 2023 revenue achievement of $216.4 million
Performance MetricsRevenue and Adjusted Free Cash FlowRevenue threshold achieved partially; adjusted free cash flow goals not achieved
Evaluation Period2023Based on the 2023 Bonus Plan
Vesting ScheduleN/A (cash-based)Cash incentive; no vesting required
Grant Date for Plan-Based AwardsFebruary 28, 2023 Establishes the period of performance measurement

Stock Awards (Restricted Stock Units - RSUs)

Metric DescriptionValueDetails/Conditions
Number of RSUs102,374 Granted in 2023
Grant DateFebruary 28, 2023 Specific grant date provided
Grant Date Fair Value$1,832,495 Total fair value of the restricted stock units granted
Vesting Schedule25% each anniversary25% vest on the first anniversary; remaining vest at 25% per year over the subsequent three years
Performance ConditionsNoneAwards are time-based with no performance metrics attached
Grant Date Stock PriceN/AStock price on grant date not provided